search buttonmobile navigation expand button

Need Assistance?

Back to Search Results


RIN-PH-202- An Open-Label Extension study of Inhaled Treprostinil in Subjects with Pulmonary Hypertension due to Parenchymal Lung Disease
The purpose of this research study is to provide or continue to provide inhaled Treprostinil to eligible subjects who participated in the RIN-PH-201 INCREASE study.  The study will also investigate the safety and how well inhaled treprostinil works in subjects with pulmonary hypertension (PH) associated with interstitial lung disease (ILD) including combined pulmonary fibrosis and emphysema (CPFE).  This study will look at your ability to exercise after taking the study drug.
Trial Information
Principal Investigator: Dr. Majid Mughal MD

Contact: Study Coordinator
Phone (Main): 517-347-1968

IRB Number: 2017-00050 02630316

More Information: